Promoter V.C. Nannapaneni has created a pledge on 8,50,000 equity shares of Natco Pharma Limited. These shares represent 0.47% of the total share capital. The purpose of this pledge is to subscribe to the company’s upcoming rights issue. This disclosure has been made in compliance with SEBI regulations, with the revised disclosure enclosed with the letter dated 4th November 2026.
Shareholder Action for Rights Issue
V.C. Nannapaneni, a promoter of Natco Pharma Limited, has formally disclosed the creation of a pledge on a significant number of shares. A total of 8,50,000 equity shares, each with a face value of Rs.2/-, have been encumbered. This action is specifically to facilitate the promoter’s subscription to the forthcoming rights issue of Natco Pharma Limited.
Disclosure Compliance
This disclosure has been made in accordance with Regulation 31(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. A prior disclosure related to this matter was made on 12th October 2026, with a subsequent email received from BSE on 3rd November 2026. The reporting date for this specific encumbrance is 12th October 2026. The pledged shares constitute 0.47% of the total share capital, with the promoter’s overall holding being 15.66% (2,80,45,905 shares) prior to this event. The entity in whose favor the shares are encumbered is Bajaj Financial Securities Limited.
Source: BSE
